ALMKT Stock Overview
A medical device company, manufactures and sells medical devices in Europe and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Mauna Kea Technologies SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.17 |
| 52 Week High | €0.53 |
| 52 Week Low | €0.15 |
| Beta | 1.37 |
| 1 Month Change | 4.84% |
| 3 Month Change | 0.60% |
| 1 Year Change | -60.51% |
| 3 Year Change | -72.65% |
| 5 Year Change | -81.93% |
| Change since IPO | -98.68% |
Recent News & Updates
Recent updates
What Mauna Kea Technologies SA's (EPA:ALMKT) 31% Share Price Gain Is Not Telling You
Jul 23
Mauna Kea Technologies SA's (EPA:ALMKT) Share Price Could Signal Some Risk
Mar 23What Is Mauna Kea Technologies SA's (EPA:MKEA) Share Price Doing?
Jan 12Mauna Kea Technologies (EPA:MKEA) Share Prices Have Dropped 70% In The Last Three Years
Nov 26Shareholder Returns
| ALMKT | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 1.0% | -2.0% | -2.8% |
| 1Y | -60.5% | 24.5% | -6.5% |
Return vs Industry: ALMKT underperformed the French Medical Equipment industry which returned 25.3% over the past year.
Return vs Market: ALMKT underperformed the French Market which returned -4.9% over the past year.
Price Volatility
| ALMKT volatility | |
|---|---|
| ALMKT Average Weekly Movement | 5.6% |
| Medical Equipment Industry Average Movement | 6.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in FR Market | 10.6% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: ALMKT has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: ALMKT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 65 | Sacha Loiseau | www.maunakeatech.com |
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally. It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
Mauna Kea Technologies SA Fundamentals Summary
| ALMKT fundamental statistics | |
|---|---|
| Market cap | €10.92m |
| Earnings (TTM) | -€11.21m |
| Revenue (TTM) | €8.16m |
1.3x
P/S Ratio-1.0x
P/E RatioIs ALMKT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALMKT income statement (TTM) | |
|---|---|
| Revenue | €8.16m |
| Cost of Revenue | €2.25m |
| Gross Profit | €5.91m |
| Other Expenses | €17.12m |
| Earnings | -€11.21m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Apr 24, 2025
| Earnings per share (EPS) | -0.17 |
| Gross Margin | 72.42% |
| Net Profit Margin | -137.49% |
| Debt/Equity Ratio | -137.6% |
How did ALMKT perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/31 07:33 |
| End of Day Share Price | 2025/03/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Mauna Kea Technologies SA is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Guillaume Cuvillier | Gilbert Dupont |
| Stephanie Lefebvre | Gilbert Dupont |
| Sachin Soni | Kempen & Co. NV |